Cardiovascular Risks With SGLT2 Inhibitors in Clinical Practice Among Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiovascular Risks With SGLT2 Inhibitors in Clinical Practice Among Patients With Type 2 Diabetes
JAMA Netw Open 2024 Oct 30;7(10)e2441765, HY Su, CY Yang, YH Lee, PF Su, YC Liu, HT OuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.